Eliglustat
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
Adverse Event Profile Differences Between Eliglustat and Miglustat: A Pharmacovigilance Study using the U.S. Food and Drug Administration Adverse Event Reporting System.
Journal: Drug research
Published: February 05, 2026
Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China.
Journal: Journal of clinical medicine
Published: January 15, 2026
Repurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.
Journal: Molecular genetics and metabolism
Published: December 16, 2025
Eliglustat prevents acute kidney injury caused by Shiga toxin 2 in lethal and sublethal rat models of hemolytic uremic syndrome.
Journal: Frontiers in pharmacology
Published: October 30, 2025
The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis.
Journal: International journal of molecular sciences
Published: August 20, 2025
Cytokine-driven glycosphingolipid metabolism modulates endoplasmic reticulum calcium homeostasis in primary human renal mesangial cells.
Journal: Frontiers in immunology
Published: August 19, 2025
Bone involvement in Gaucher disease: Data from a North African registry.
Journal: Reumatologia clinica
Published: July 17, 2025
Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors.
Journal: Metabolites
Published: May 22, 2025
Exploring the hub gene CERS6 as a therapeutic target in type 1 diabetes through a bioinformatics and network analyst approach.
Journal: Scientific reports
Published: April 10, 2025
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics.
Journal: Pharmacogenomics
Published: April 07, 2025
In Vivo Accumulation of Regulatory T Cells Using Eliglustat-Loaded Cryogels.
Journal: Advanced healthcare materials
Published: March 22, 2025
Eliglustat substrate reduction therapy in children with Gaucher disease type 1.
Journal: Frontiers in pediatrics
Published: December 10, 2024
Last Updated: 04/28/2026